Overview

Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation

Status:
Completed
Trial end date:
2016-11-04
Target enrollment:
Participant gender:
Summary
A study of the safety of lubiprostone in pediatric participants aged ≥ 6 Years to < 18 years diagnosed with functional constipation.
Phase:
Phase 3
Details
Lead Sponsor:
Sucampo Pharma Americas, LLC
Collaborator:
Sucampo AG
Treatments:
Lubiprostone